# UNLOXCYT
> **BLA761297** · Biologics License Application · Sponsor: CHECKPOINT THERAPEUTICS INC · Approved 2024-12-13
## Drug
- **FDA Application Number:** BLA761297
- **Application type:** Biologics License Application
- **Brand name:** UNLOXCYT
- **Generic name:** COSIBELIMAB
- **Active ingredients:** COSIBELIMAB-IPDL
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** CHECKPOINT THERAPEUTICS INC
- **Manufacturer:** Sun Pharmaceutical Industries, Inc.
- **First approval:** 2024-12-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761297)
---
*MORVS · CC0 1.0*